Warning letter
Oskri Corp.: warning letter of Jan 21, 2014
FDA warning letter 410199 · Minneapolis District Office
Key facts
| Reference number | 410199 |
|---|---|
| Company | Oskri Corp. |
| Subject | CGMP For Manufacturing, Packing, or Holding Human Food/Adulterated |
| Issue date | Jan 21, 2014 |
| Posted date | Jan 28, 2014 |
| Issuing office | Minneapolis District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.4(b)(2), 101, 101.3, 101.100, 110, 74.705(d)(2), 101.9, 101.9(b)(8)(iv), 101.9(c)(1)(ii), 110.10(c), 101.9(c)(7)(i), 110.20(b)(6) and 12 more |
| Inspection city | Lake Mills |
| Inspection ZIP | 53551 |
| Inspection start date | May 22, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: